These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29561509)

  • 1. In Vitro Study on the Effect of Maraviroc or Dolutegravir on Bilirubin to Albumin Binding.
    Schreiner CN; Ahlfors CE; Wong RJ; Stevenson DK; Clarke DF; Mirochnick M
    Pediatr Infect Dis J; 2018 Sep; 37(9):908-909. PubMed ID: 29561509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The displacement of bilirubin from albumin by furosemide.
    Shankaran S; Poland RL
    J Pediatr; 1977 Apr; 90(4):642-6. PubMed ID: 839387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Displacement of bilirubin from human albumin by three diuretics.
    Wennberg RP; Rasmussen F; Ahlfors CE
    J Pediatr; 1977 Apr; 90(4):647-50. PubMed ID: 839388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative disposition and metabolism of dolutegravir, a potent HIV-1 integrase inhibitor, in mice, rats, and monkeys.
    Moss L; Wagner D; Kanaoka E; Olson K; Yueh YL; Bowers GD
    Xenobiotica; 2015 Jan; 45(1):60-70. PubMed ID: 25034010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
    Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Displacement of albumin-bound antimicrobial agents by bilirubin.
    Bratlid D; Bergan T
    Pharmacology; 1976; 14(5):464-72. PubMed ID: 1031216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the binding characteristics of serum albumins from various animal species.
    Robertson A; Karp W; Brodersen R
    Dev Pharmacol Ther; 1990; 15(2):106-11. PubMed ID: 2078971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program.
    Descamps D; Peytavin G; Visseaux B; Tubiana R; Damond F; Campa P; Charpentier C; Khuong-Josses MA; Duvivier C; Karmochkine M; Lukiana T; Matheron S
    Clin Infect Dis; 2015 May; 60(10):1521-7. PubMed ID: 25690598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sulfisoxazole, hypercarbia, and hyperosmolality on entry of bilirubin and albumin into brain regions in young rats.
    Hansen TW; Oyasaeter S; Stiris T; Bratlid D
    Biol Neonate; 1989; 56(1):22-30. PubMed ID: 2503067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between protein binding of bilirubin, salicylic acid, and sulfisoxazole in serum of unmedicated and phenobarbital-treated rats.
    Yacobi A; Oie S; Levy G
    J Pharm Sci; 1977 Jul; 66(7):1025-7. PubMed ID: 886438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilirubin-albumin binding and a possible mechanism of kernicterus.
    Lee JJ; Cowger ML
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):327-39. PubMed ID: 4859223
    [No Abstract]   [Full Text] [Related]  

  • 12. Bilirubin-albumin binding and free bilirubin.
    Ahlfors CE
    J Perinatol; 2001 Dec; 21 Suppl 1():S40-2; discussion S59-62. PubMed ID: 11803415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Displacement of bilirubin from albumin in plasma from jaundiced newborns. An in vitro study of purified Chinese herbal constituents and sulfisoxazole.
    Soligard HT; Bratlid D; Cao C; Liang A; Nilsen OG
    Phytother Res; 2011 Jul; 25(7):1068-72. PubMed ID: 21280114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Displacement of bilirubin from albumin by indomethacin.
    Rasmussen LF; Ahlfors CE; Wennberg RP
    J Clin Pharmacol; 1978 Oct; 18(10):477-81. PubMed ID: 711930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients.
    Zhang J; Hayes S; Sadler BM; Minto I; Brandt J; Piscitelli S; Min S; Song IH
    Br J Clin Pharmacol; 2015 Sep; 80(3):502-14. PubMed ID: 25819132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raltegravir in vitro effect on bilirubin binding.
    Clarke DF; Wong RJ; Wenning L; Stevenson DK; Mirochnick M
    Pediatr Infect Dis J; 2013 Sep; 32(9):978-80. PubMed ID: 23470680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance.
    Hardy I; Brenner B; Quashie P; Thomas R; Petropoulos C; Huang W; Moisi D; Wainberg MA; Roger M
    J Antimicrob Chemother; 2015 Feb; 70(2):405-11. PubMed ID: 25281399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bilirubin displacement effect by acetaminophen in vitro.
    Sugino M; Okada H; Kusaka T; Itoh S
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):476-80. PubMed ID: 25525256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.
    Rathbun RC; Lockhart SM; Miller MM; Liedtke MD
    Ann Pharmacother; 2014 Mar; 48(3):395-403. PubMed ID: 24259658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Displacement of bilirubin from albumin by ibuprofen in vitro.
    Soligard HT; Nilsen OG; Bratlid D
    Pediatr Res; 2010 Jun; 67(6):614-8. PubMed ID: 20216106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.